Baird Maintains Outperform on Applied Therapeutics, Raises Price Target to $43

Baird analyst Brian Skorney maintains Applied Therapeutics (NASDAQ:APLT) with a Outperform and raises the price target from $24 to $43.

Benzinga · 01/08/2020 17:23

Baird analyst Brian Skorney maintains Applied Therapeutics (NASDAQ:APLT) with a Outperform and raises the price target from $24 to $43.